Fatal purpura fulminans and Waterhouse-Friderichsen syndrome from fulminant Streptococcus pneumoniae sepsis in an asplenic young adult

IDCases

Volumn 6, Issue , 2016, Pages 1-4

  Hale, Andrew J ^a   LaSalvia, Mary ^a   Kirby, James E ^a   Kimball, Allison ^a   Baden, Rachel ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Alameda Health System   (United States)

Author keywords

Asplenia; Purpura fulminans; Sepsis; Streptococcus pneumoniae; Waterhouse Friderichsen syndrome

Indexed keywords

CEFTRIAXONE; CLINDAMYCIN; DOXYCYCLINE; LAMOTRIGINE; PNEUMOCOCCUS VACCINE; QUININE; SULFONAMIDE; TRAZODONE; VANCOMYCIN;

ABDOMINAL PAIN; ADRENAL CORTEX INSUFFICIENCY; ADRENAL HEMORRHAGE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ASPLENIA; AUTOPSY; CASE REPORT; DIARRHEA; DIFFERENTIAL DIAGNOSIS; EPIDEMIC MENINGITIS; FEMALE; FEVER; HUMAN; NAUSEA AND VOMITING; PIROPLASMOSIS; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PURPURIC RASH; RESPIRATORY FAILURE; SEPSIS; THROMBOCYTOPENIC PURPURA;

EID: 84983611806     PISSN: 22142509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idcr.2016.08.004     Document Type: Article

References (21)

1. [1] Bisno, A.L., Freeman, J.C., The syndrome of asplenia, pneumococcal sepsis, and disseminated intravascular coagulation. Ann Intern Med 72 (1970), 389–393 PMID 5415422.
2. [2] Rubin, L.G., Schaffner, W., Care of the asplenic patient. N Engl J Med, 371, 2014, 349 PMID 25054718.
3. [3] Pilishvili, T., Lexau, C., Farley, M.M., et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 201 (2010), 32–41 PMID 19947881.
4. [4] Waghorn, D.J., Mayon-White, R.T., A study of 42 episodes of overwhelming post-splenectomy infection: is current guidance for asplenic individuals being followed?. J Infect 35:November (3) (1997), 289–294.
5. [5] White, B., Livingstone, W., Murphy, C., Hodgson, A., Rafferty, M., Smith, O.P., An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia. Blood 96:December (12) (2000), 3719–3724 PMID 11090052.
6. [6] Waterhouse, R., A case of suprarenal apoplexy. Lancet 1 (1911), 577–578.
7. [7] Krause, P.J., Gewurz, B.E., Hill, D., Marty, F.M., Vannier, E., Foppa, I.M., et al. Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis, 46(3), 2008, 370 PMID 18181735.
8. [8] Wald, K., Martinez, A., Moll, S., Capnocytophaga canimorsus infection with fulminant sepsis in an asplenic patient: diagnosis by review of peripheral blood smear. Am J Hematol, 83(November (11)), 2008, 879 PMID 18098127.
9. [9] Bisharat, N., Omari, H., Lavi, I., Raz, R., Risk of infection and death among postsplenectomy patients. J Infect 43 (2001), 182–186 PMID 11798256.
10. [10] Puar, T., Stikkelbroeck, N., Smans, L., Zelissen, P., Hermus, A., Adrenal crisis: still a deadly event in the 21 st century. Am J Med, 129(March (3)), 2015, 339 e1-339. e9. PMID 26363354.
11. [11] Margaretten, W., Nakai, H., Landing, B., Septicemic adrenal hemorrhage. Am J Dis Child 105 (1963), 346–351 PMID 139322989.
12. [12] Vincentelli, C., Molna, E.G., Robinson, M.J., Fatal pneumococcal Waterhouse-Friderichsen syndrome in a vaccinated adult with congenital asplenia. Am J Emerg Med, 27(July (6)), 2009, 751 e3-5. PMID 19751638.
13. [13] Bernard, G., Vincent, J.L., Laterre, P.F., LaRosa, S., Dhainaut, J., Lopez-Rodriguez, A., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:March (8) 2001 (2001), 699–709 PMID 11236773.
14. [14] Ranieri, V., Thompson, B., Barie, P., Dhainaut, J.F., Douglas, I., Finfer, S., et al. Drotrecogin alfa (Activated) in adults with septic shock. N Engl J Med 366 (2012), 2055–2064 PMID 22616830.
15. [15] Martí-Carvajal, A.J., Solà, I., Gluud, C., Lathyris, D., Cardona, A.F., Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients. Cochrane Database Syst Rev, 12(December), 2012 PMID 23235609.
16. [16] Smith, O.P., White, B., Vaughan, D., Rafferty, M., Claffey, L., Lyons, B., et al. Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans. Lancet 350:November (9091) (1997), 1590–1593 PMID 9393338.
17. [17] Veldman, A., Fischer, D., Wong, F.Y., Kreuz, W., Sasse, M., Eberspächer, B., et al. Human protein C concentrate in the treatment of purpura fulminans: a retrospective analysis of safety and outcome in 94 pediatric patients. Crit Care, 14(4), 2010, R156, 10.1186/cc9226 Epub 2010 Aug 19, PMID 20723255.
18. [18] de Kleijn, E.D., de Groot, R., Hack, C.E., Mulder, P.G., Engl, W., Moritz, B., et al. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study. Crit Care Med 31:June (6) (2003), 1839–1847 PMID12794428.
19. [19] Gaston, M.H., Verter, J.I., Woods, G., Pegelow, C., Kelleher, J., Presbury, G., et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 314:June (25) (1986), 1593–1599 PMID3086721.
20. [20] Falletta, J.M., Woods, G.M., Verter, J.I., Buchanan, G.R., Pegelow, C.H., Iyer, R.V., et al. Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II. J Pediatr 127:November (5) (1995), 685–690 PMID 7472817.
21. [21] Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force, Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. BMJ 312:February (7028) (1996), 430–434 PMID 8601117.